ERIS
Invest with MTF
Invest Now
Invest in Eris Lifesciences with 3.34X leverage
Performance
- Low
- ₹1,384
- High
- ₹1,434
- 52 Week Low
- ₹1,097
- 52 Week High
- ₹1,910
- Open Price₹1,416
- Previous Close₹1,413
- Volume25,808
- 50 DMA₹1,484.18
- 100 DMA₹1,534.59
- 200 DMA₹1,533.82
Investment Returns
- Over 1 Month -7.8%
- Over 3 Month -9.74%
- Over 6 Month -17.03%
- Over 1 Year -1.56%
Smart Investing Starts Here Start SIP with Eris Lifesciences for Steady Growth!
Eris Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 47.7
- PEG Ratio
- 2.5
- Market Cap Cr
- 19,823
- P/B Ratio
- 6.4
- Average True Range
- 47.51
- EPS
- 30.02
- Dividend Yield
- 0.5
- MACD Signal
- -37.72
- RSI
- 48.05
- MFI
- 29.67
Eris Lifesciences Financials
Eris Lifesciences Technicals
EMA & SMA
Current Price
₹1,431.00
+
17.8
(1.26%)
- Bearish Moving Average 9
- Bullish Moving Average 7
- 20 Day
- ₹1,425.96
- 50 Day
- ₹1,484.18
- 100 Day
- ₹1,534.59
- 200 Day
- ₹1,533.82
Resistance and Support
1416.27
- R3 1,498.33
- R2 1,466.07
- R1 1,448.53
- S1 1,398.73
- S2 1,366.47
- S3 1,348.93
Eris Lifesciences Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-24 | Preferential issue of shares | Inter-alia, To consider the protposal of issuance ofequity shares of the Company by way of a preferential issue for consideration other than cash.. per share(601%)Interim Dividend |
| 2025-11-12 | Quarterly Results | |
| 2025-08-05 | Quarterly Results | |
| 2025-05-19 | Audited Results | |
| 2025-02-07 | Interim Dividend |
Eris Lifesciences F&O
About Eris Lifesciences
- NSE Symbol
- ERIS
- BSE Symbol
- 540596
- Chairperson & Managing Director
- Mr. Amit Bakshi
- ISIN
- INE406M01024
Similar Stocks to Eris Lifesciences
Eris Lifesciences FAQs
Eris Lifesciences share price is ₹1,431 As on 07 February, 2026 | 12:33
The Market Cap of Eris Lifesciences is ₹19822.7 Cr As on 07 February, 2026 | 12:33
The P/E ratio of Eris Lifesciences is 47.7 As on 07 February, 2026 | 12:33
The PB ratio of Eris Lifesciences is 6.4 As on 07 February, 2026 | 12:33
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.